Aileron Therapeutics Inc (ALRN)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-SOCIAL SERVICES
CEO:
Manuel C. Alves Aivado
Employees:
9
281 ALBANY STREET, CAMBRIDGE, MA 02139
617-995-0900

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. Company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma.

Data derived from most recent annual or quarterly report
Market Cap 126.245 Million Shares Outstanding90.824 Million Avg 30-day Volume 64.515 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.07
Price to Revenue0.0 Debt to Equity0.0 EBITDA-25.803 Million
Price to Book Value1.1386 Operating Margin0.0 Enterprise Value4.031 Million
Current Ratio10.687 EPS Growth-0.237 Quick Ratio10.189
1 Yr BETA 0.9227 52-week High/Low 15.0 / 1.25 Profit Margin0.0
Operating Cash Flow Growth-16.009 Altman Z-Score-1.235 Free Cash Flow to Firm -18.806 Million

Are you looking for this stock instead?

View SEC Filings from ALRN instead.

View recent insider trading info

Aileron Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding ALRN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ALRN

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-06-17 by MORRISON JODIE POPE
  • 4: filed on 2022-06-17 by MCKEE WILLIAM
  • 4: filed on 2022-06-17 by VON RICKENBACH JOSEF H
  • 4: filed on 2022-06-17 by SIGAL NOLAN HOWARD
  • 3: filed on 2022-06-17 by DREXLER SUSAN L.
  • 4: filed on 2022-06-17 by AMBROS REINHARD J.
  • 4: filed on 2022-06-17 by BAILEY JEFFREY ALLEN
  • 4/A: filed on 2022-03-30 by AIVADO MANUEL
  • 4/A: filed on 2022-03-30 by VUKOVIC VOJO
  • 4/A: filed on 2022-03-30 by WANSTALL RICK

    • Events (8k)

  • 8-K: filed on 2023-02-23:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 8.01: Other Events
  • 8-K: filed on 2022-11-10:
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-29:
    Item 8.01: Other Events
  • 8-K: filed on 2022-06-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-06-08:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • 8-K: filed on 2022-06-07:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-04-29:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-01-05:
    Item 8.01: Other Events
  • 8-K: filed on 2021-12-07:
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    VON RICKENBACH JOSEF H

    • Director
    		 54,500 2022-06-15 1

    MCKEE WILLIAM

    • Director
    		 54,500 2022-06-15 1

    SIGAL NOLAN HOWARD

    • Director
    		 54,500 2022-06-15 1

    MORRISON JODIE POPE

    • Director
    		 54,500 2022-06-15 1

    AMBROS REINHARD J.

    • Director
    		 54,500 2022-06-15 1

    DREXLER SUSAN L. SEE REMARKS

    • Officer
    		 0 2022-06-15 1

    VUKOVIC VOJO CHIEF MEDICAL OFFICER

    • Officer
    		 150,000 2022-03-30 1

    ANNIS ALLEN SVP, RESEARCH

    • Officer
    		 313,000 2022-03-30 1

    AIVADO MANUEL SEE REMARKS

    • Officer
    • Director
    		 1,133,000 2022-03-30 1

    WANSTALL RICK SEE REMARKS

    • Officer
    		 393,000 2022-03-30 1

    BAILEY JEFFREY ALLEN

    • Director
    		 96,000 2021-06-15 0

    SATTER MUNEER A SEE REMARKS

    • Officer
    • Director
    		 16,609,449 2021-01-08 0

    GREGORY KATHRYN SVP, CHIEF BUSINESS OFFICER

    • Officer
    		 0 2020-01-31 0

    MCARTHUR JOHN H

    • Director
    		 0 2019-06-19 0

    DOUGHERTY DONALD SVP & CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2019-04-15 0

    NOVARTIS BIOVENTURES LTD

    NOVARTIS AG

    • 10% Owner
    		 No longer subject to file 2019-03-29 0

    LONGENECKER JOHN P PHD PRESIDENT AND CEO

    • Officer
    		 10,000 2018-08-10 0

    APPLE TREE PARTNERS II LP

    • 10% Owner
    		 No longer subject to file 2018-07-06 0

    APPLE TREE PARTNERS II - ANNEX, L.P.

    • 10% Owner
    		 No longer subject to file 2018-07-06 0

    SHANAFELT ARMEN

    • Director
    		 0 2018-06-21 0

    WINDER CALEB MAXFIELD

    • Director
    		 0 2018-06-21 0

    YANCHIK JOSEPH A., III SEE REMARKS

    • Officer
    • Director
    		 0 2017-07-25 0

    NELSON KIRA SEE REMARKS

    • Officer
    		 0 2017-07-25 0

    KAPNICK SCOTT

    • Director
    		 0 2017-07-25 0

    GALLAGHER BRIAN M. JR.

    • Director
    		 0 2017-07-25 0

    ROCHE HOLDING LTD

    ROCHE FINANCE LTD

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    CVF, LLC

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    EXCEL MEDICAL FUND LP

    GULLANS STEVEN R. PH.D.

    BLUME FREDERICK R.

    ENRIQUEZ JUAN

    EXCEL MEDICAL VENTURES, LLC

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    LV MANAGEMENT GROUP, LLC

    LILLY VENTURES FUND I LLC

    TORRES S. EDWARD

    HALL STEVEN EDWARD

    • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2017-07-05 0

    PLATT JON B.

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    KCK LTD.

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    SIGMA EMERGING MARKETS LTD.

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    AJU IB INVESTMENT CO., LTD.

    • 10% Owner
    		 No longer subject to file 2017-07-05 0

    GLAXOSMITHKLINE PLC

    • 10% Owner
    		 0 2017-06-28 0

    GELMAN GARY CHAIRMAN, PRESIDENT & CEO

    • Officer
    • Director
    • 10% Owner
    		 2,896,400 2012-01-03 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AILERON THERAPEUTICS INC ALRN 2023-03-24 22:15:03 UTC -9.646 14.466 70000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 21:45:03 UTC -9.646 14.466 70000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 21:15:03 UTC -9.646 14.466 70000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 20:45:03 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 20:15:04 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 19:45:03 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 19:15:04 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 18:45:04 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 18:15:03 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 17:45:03 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 17:15:03 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 16:45:03 UTC -7.809 12.629 75000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 16:15:03 UTC -7.809 12.629 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 15:45:03 UTC -7.809 12.629 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 15:15:03 UTC -7.809 12.629 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 14:45:03 UTC -7.809 12.629 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 14:15:03 UTC -7.809 12.629 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 13:45:03 UTC -9.3853 13.9553 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 13:15:04 UTC -9.3853 13.9553 55000
    AILERON THERAPEUTICS INC ALRN 2023-03-24 12:45:03 UTC -9.3853 13.9553 85000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments